Thomas Enzlein

412 total citations
16 papers, 237 citations indexed

About

Thomas Enzlein is a scholar working on Molecular Biology, Spectroscopy and Physiology. According to data from OpenAlex, Thomas Enzlein has authored 16 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Spectroscopy and 6 papers in Physiology. Recurrent topics in Thomas Enzlein's work include Metabolomics and Mass Spectrometry Studies (7 papers), Mass Spectrometry Techniques and Applications (7 papers) and Alzheimer's disease research and treatments (6 papers). Thomas Enzlein is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (7 papers), Mass Spectrometry Techniques and Applications (7 papers) and Alzheimer's disease research and treatments (6 papers). Thomas Enzlein collaborates with scholars based in Germany, Belgium and United States. Thomas Enzlein's co-authors include Carsten Hopf, Martina Blank, Lucía Chávez‐Gutiérrez, Katarzyna Marta Zoltowska, María Szaruga, Elizabeth Hill, Sara Gutiérrez Fernández, Rik Vandenberghe, Nick C. Fox and Natalie S. Ryan and has published in prestigious journals such as Nature Communications, The EMBO Journal and Bioinformatics.

In The Last Decade

Thomas Enzlein

15 papers receiving 236 citations

Peers

Countries citing papers authored by Thomas Enzlein

Since Specialization

Citations

This map shows the geographic impact of Thomas Enzlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Enzlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Enzlein more than expected).

Fields of papers citing papers by Thomas Enzlein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Enzlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Enzlein. The network helps show where Thomas Enzlein may publish in the future.

Co-authorship network of co-authors of Thomas Enzlein

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Enzlein. A scholar is included among the top collaborators of Thomas Enzlein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Enzlein. Thomas Enzlein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Exploring the Aβ Plaque Microenvironment in Alzheimer’s Disease Model Mice by Multimodal Lipid-Protein-Histology Imaging on a Benchtop Mass Spectrometer 2025 ·Pharmaceuticals ·Elisabeth Müller, Thomas Enzlein, (unknown), (unknown), Katherine A. Stumpo, Knut Biber, Corinna Klein, Carsten Hopf	2
2	Deep MALDI-MS spatial omics guided by quantum cascade laser mid-infrared imaging microscopy 2025 ·Nature Communications ·(unknown), S. Schmidt, Thomas Enzlein, (unknown), (unknown), (unknown), (unknown), (unknown), Martina Kerndl, Denis Abu Sammour, Omar Sharif, Gernot Schabbauer, Rüdiger Rudolf, Matthias Eckhardt, (unknown), Laura Bîndilă, Carsten Hopf	6
3	pyM2aia: Python interface for mass spectrometry imaging with focus on deep learning 2024 ·Bioinformatics ·(unknown), Thomas Enzlein, Carsten Hopf, Ivo Wolf	2
4	Label-free assessment of complement-dependent cytotoxicity of therapeutic antibodies via a whole-cell MALDI mass spectrometry bioassay 2024 ·Scientific Reports ·S. Schmidt, (unknown), Thomas Enzlein, (unknown), (unknown), (unknown), C. Graf, Carsten Hopf	0
5	Integrative Single-Plaque Analysis Reveals Signature Aβ and Lipid Profiles in the Alzheimer’s Brain 2024 ·Analytical Chemistry ·Thomas Enzlein, Tammaryn Lashley, Denis Abu Sammour, Carsten Hopf, Lucía Chávez‐Gutiérrez	10
6	APP substrate ectodomain defines amyloid‐β peptide length by restraining γ‐secretase processivity and facilitating product release 2023 ·The EMBO Journal ·(unknown), Thomas Enzlein, Shuyu Chen, (unknown), Sam Lismont, Martin Zacharias, Carsten Hopf, Lucía Chávez‐Gutiérrez	7
7	Alzheimer’s disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signaling 2023 ·eLife ·Katarzyna Marta Zoltowska, (unknown), Sam Lismont, Thomas Enzlein, Masato Maesako, (unknown), (unknown), (unknown), (unknown), (unknown), Ann Becker, Carsten Hopf, Marçal Vilar, Oksana Berezovska, William C. Mobley, Lucía Chávez‐Gutiérrez	5
8	Aβ profiles generated by Alzheimer’s disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onset 2022 ·Molecular Psychiatry ·(unknown), Sara Gutiérrez Fernández, Katarzyna Marta Zoltowska, Thomas Enzlein, Natalie S. Ryan, Antoinette O’Connor, María Szaruga, Elizabeth Hill, Rik Vandenberghe, Nick C. Fox, Lucía Chávez‐Gutiérrez	68
9	Enzyme–substrate interface targeting by imidazole‐based γ‐secretase modulators activates γ‐secretase and stabilizes its interaction with APP 2022 ·The EMBO Journal ·(unknown), Manuel Hitzenberger, (unknown), Sam Lismont, Katarzyna Marta Zoltowska, Thomas Enzlein, Carsten Hopf, Martin Zacharias, Lucía Chávez‐Gutiérrez	10
10	LPS-induced lipid alterations in microglia revealed by MALDI mass spectrometry-based cell fingerprinting in neuroinflammation studies 2022 ·Scientific Reports ·Martina Blank, Thomas Enzlein, Carsten Hopf	28
11	Following spatial Aβ aggregation dynamics in evolving Alzheimer’s disease pathology by imaging stable isotope labeling kinetics 2021 ·Science Advances ·Wojciech Michno, (unknown), Thomas Enzlein, Melissa K. Passarelli, Stéphane Escrig, (unknown), (unknown), Kaj Blennow, Henrik Zetterberg, Anders Meibom, Carsten Hopf, Frances A. Edwards, Jörg Hanrieder	24
12	Label-free cell assays to determine compound uptake or drug action using MALDI-TOF mass spectrometry 2021 ·Nature Protocols ·(unknown), Martina Blank, Thomas Enzlein, Carsten Hopf	16
13	M2aia—Interactive, fast, and memory-efficient analysis of 2D and 3D multi-modal mass spectrometry imaging data 2021 ·GigaScience ·(unknown), Thomas Enzlein, Christian Marsching, (unknown), Sandy Engelhardt, Carsten Hopf, Ivo Wolf	18
14	Computational Analysis of Alzheimer Amyloid Plaque Composition in 2D- and Elastically Reconstructed 3D-MALDI MS Images 2020 ·Analytical Chemistry ·Thomas Enzlein, (unknown), Bogdan Munteanu, Wojciech Michno, Lutgarde Serneels, Bart De Strooper, Jörg Hanrieder, Ivo Wolf, Lucía Chávez‐Gutiérrez, Carsten Hopf	19
15	Direct Automated MALDI Mass Spectrometry Analysis of Cellular Transporter Function: Inhibition of OATP2B1 Uptake by 294 Drugs 2020 ·Analytical Chemistry ·(unknown), (unknown), Thomas Enzlein, (unknown), Maciej J. Zamek‐Gliszczynski, Matthias Schwab, Anne T. Nies, Gerard Drewes, Sandra Schulz, Friedrich Reinhard, Carsten Hopf	9
16	Impact of Mistletoe Triterpene Acids on the Uptake of Mistletoe Lectin by Cultured Tumor Cells 2016 ·PLoS ONE ·(unknown), Thomas Enzlein, (unknown), Sebastian Jaeger, Georg Seifert, Matthias F. Melzig	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact